TRILC.E.IS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 14, 2025
Report Source: 2025 1st Quarter Report
T
Turk Ilac ve Serum Sanayi AS. Stock Analysis TRILC.E.IS
Türk Ilaç ve Serum Sanayi AS engages in the manufacture of medical drugs. The main activity of the Company is to manufacture and sell all kinds of tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids and other chemical substances. The firm also acts as the representative or sales agency of other domestic and foreign pharmaceutical companies, as well as importing and marketing veterinary, cosmetics and pesticides. Turk Ilac manufactures in accordance with Current Good Manufacturing (GMP) and Good Laboratory Practice (GLP) principles with its approximately 300 employees in its facilities on a total area of 56.000 square meters in the Ankara - Akyurt region.
Read More Turk Ilac ve Serum Sanayi AS (TRILC.E.IS) Chart
Key Statistics of Turk Ilac ve Serum Sanayi AS (TRILC.E.IS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
TRY3.09Volume
83.89MP/E Ratio (TTM)
-52 Week Range
Market Cap
3.89BAvg. Volume
134.62MDividend Yield
-Financial Metrics & Statements of Turk Ilac ve Serum Sanayi AS (TRILC.E.IS)
FAQ's for Turk Ilac ve Serum Sanayi AS (TRILC.E.IS)
- According to Musaffa’s Shariah screening methodology, Turk Ilac ve Serum Sanayi AS (TRILC.E.IS) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.